HolingerPHBrownWT. Congenital webs, cysts, laryngoceles, and other anomalies of the larynx. Ann Otol Rhinol Laryngol1976;76:744–52.
2.
HolingerLDKoniorRJRussellEJ. Superselective embolization of laryngeal hemangioma. Laryngoscope1988; 98: 830–4.
3.
ShikhaniAHMarshBRJonesMMHollidayMJ. Infantile subglottic hemangiomas: An update. Ann Otol Rhinol Laryngol1986;95:336–47.
4.
MeeuwisJBosCEHoeveLJVan der VoortE. Subglottic hemangiomas in infants: Treatment with intralesional corticosteroid injection and intubation. Int J Pediatric Otorhinolaryngol1990;22:85–90.
5.
SeidABPranksySMKearnsDB. The open surgical approach to subglottic hemangioma. Int J Pediatric Otorhinolaryngol1991;22:85–90.
6.
MulderJJSVan den BroekP. Surgicalk treatment of infantile subglottic hemangioma. Int J Pediatric Otorhinolaryngol1989;17:57–63.
7.
JacksonITCarrenoRPotparicZHussainK. Hemangiomas, vascular malformations and lymphovenous malformations: Classification and methods of treatment. Plast Reconstr Surg1993;91:1216–30.
8.
GelbertFRicheMCReizineD, et al. MR imaging of head and neck vascular malformations. J Magn Reson Imaging1991;1:579–84.
9.
ClarkDE. Association of irradiation with cancer of the thyroid in children and adolescents. JAMA1959;159:1007–9.
10.
KarjaJPalvaAJokininK. Cryotherapy in the treatment of subglottic hemangioma in infants. Acta Otolaryngol (Stockh)1979;360 (suppl):58–60.
11.
EnjolrasERicheMCMerlandJJEscandeJP. Management of alarming hemangiomas in infancy: A review of 25 cases. Pediatrics1990;85:491–8.
12.
ZaremHEdgertonM. Induced resolution of cavernous hemangiomas following prednisone therapy. Plast Reconstr Surg1967;39:76–83.
13.
KarzHAskinJ. Multiple hemangiomata with thrombocytopenia. Am J Dis Child1968;115:351–7.
14.
HawkinsDBCrockettDMKahlstromEJMacLaughlinEF. Corticosteroid management of airway hemangiomas: Long-term follow-up. Laryngoscope1984;94:633–7.
CottonRTTewfikTL. Laryngeal stenosis following carbon dioxide laser in subglottic hemangioma. Report of three cases. Ann Otol Rhinol Laryngol1985; 94: 494–7.
17.
WhiteC. Treatment of hemangiomatosis with recombinant interferon alpha. Semin Hematol1990;27(suppl 4:15–22.
